Our clients get the best chance at securing
affordable coverage due to the many companies in our portfolio.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide,
coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates
due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the
Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program
due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
We recently lowered our payment for breast pumps primarily
due to the
Affordable Care Act's requirement to provide
coverage of breast pumps for our members and to bring our payment for breast pumps more in line with current market prices.»
Carolyn also had the courage of her convictions from the very start in supporting the historic health care reform legislation which will expand
coverage for 32 million Americans, make prescription drugs more
affordable for seniors, and stop insurance companies from denying health care
due to consumers» pre-existing conditions.
Many disaster relief and
affordable housing projects flounder
due to the inability to find
coverage —
coverage that is widely available in every other state.
«
Due to the
Affordable Care Act, Medicare is now providing
coverage for evidence - based preventive services with no co-payments.
That's mostly
due to either not knowing the
coverage is available, or not realizing how
affordable it can be.
Admittedly, there are companies that don't want to write renters policies in the area
due to the risk from the water, but Effective
Coverage has coastal risk renters insurance specialists on staff to make it possible to get the
coverage you need quickly and at an
affordable price.
Seniors enjoy longer life expectancies
due to medical advances, so getting
affordable life insurance
coverage no longer presents insurmountable obstacles for older citizens.
That's mostly
due to either not knowing the
coverage is available, or not realizing how
affordable it can be.
Due to increases in the cost - of - living and higher amounts of household debt, consumers may be more focused on getting the
coverage amounts they need at the most
affordable price,» James Scanlon, Director of Research at LIMRA
Although the premiums remain level, they might be more
affordable than a level term life policy
due to the decreasing nature of the
coverage.
To cover medical emergencies and other losses that could possibly occur
due to your prolonged stay, HDFC ERGO student travel insurance offers a plethora of
coverage and benefits at a very
affordable premium for your desired duration.
Today however
due to the stiff competition among the many companies offering auto insurance policies
affordable insurance
coverage can now be achieved.
In order to maintain continuous and
affordable coverage, make sure that you pay all of your
dues in a timely manner.
Coming from an immigrant community where we experience higher uninsured rates, Obamacare was a new opportunity for my family to get
affordable coverage and to get insured without being discriminated against
due to pre-existing conditions.